Seabuckthorn Seed Oil (Hippophae rhamnoides)

Seabuckthorn seed oil is extracted from the seeds of Hippophae rhamnoides and is rich in omega-3 and omega-6 fatty acids, particularly linoleic acid and alpha-linolenic acid, along with tocopherols and phytosterols. Its primary mechanisms involve modulating platelet aggregation and lipid metabolism through incorporation of polyunsaturated fatty acids into cell membrane phospholipids.

Origin & History

Seabuckthorn seed oil is derived from the seeds of Hippophae rhamnoides L., a deciduous shrub native to Europe and Asia that thrives in harsh environments like the Himalayas and Tibetan Plateau. The oil is typically extracted using supercritical CO2 methods or cold-pressing to preserve bioactive lipids, yielding a fixed oil rich in unsaturated fatty acids including omega-3, omega-6, and the rare omega-7 palmitoleic acid.

Historical & Cultural Context

Sea buckthorn has been used for over 1000 years in Traditional Chinese Medicine and Tibetan medicine for wound healing, burns, cardiovascular health, and inflammation. Historical texts document its role in treating skin lesions, dyslipidemia, and as a general tonic in Asian medical systems, with seed oil or pulp applied topically or taken orally.

Health Benefits

• Cardiovascular support: Small RCT (n=11) showed reduced platelet aggregation with berry oil supplementation (Evidence: Preliminary RCT)
• Lipid metabolism: Dose-dependent increases in serum palmitoleic acids observed in crossover trial (n=13), though no significant changes in glucose or lipids (Evidence: Small RCT)
• Wound healing: Rat studies showed significant wound contraction and increased hydroxyproline with topical/oral administration versus standard treatment (Evidence: Preclinical only)
• Skin cell regulation: In vitro studies demonstrate pro-proliferative effects on keratinocytes at low dilutions while inhibiting dysplastic cell migration (Evidence: In vitro only)
• Traditional inflammation support: Used for over 1000 years in TCM and Tibetan medicine, though human RCTs for anti-inflammatory effects not provided (Evidence: Traditional use)

How It Works

Seabuckthorn seed oil's linoleic acid (omega-6) and alpha-linolenic acid (omega-3) compete with arachidonic acid for cyclooxygenase and lipoxygenase enzymes, thereby reducing thromboxane A2 synthesis and platelet aggregation. Supplementation raises serum palmitoleic acid (C16:1n-7) levels in a dose-dependent manner, which may improve insulin sensitivity by modulating PPAR-alpha and PPAR-gamma receptor activity. Phytosterols such as beta-sitosterol in the oil competitively inhibit intestinal cholesterol absorption via NPC1L1 transporter displacement.

Scientific Research

Human clinical evidence for seabuckthorn seed oil is limited to small RCTs, with the largest being a crossover trial (n=13) testing escalating doses of 380-1520 mg/day showing bioavailability but no metabolic changes (PMID not provided). Other small studies include an RCT on berry oil and platelet aggregation (n=11) and observational data on cardiovascular markers, while wound healing evidence remains preclinical (PMID: 19425187).

Clinical Summary

A small randomized controlled trial (n=11) demonstrated that seabuckthorn berry oil supplementation significantly reduced platelet aggregation, suggesting cardiovascular benefit, though seed oil specifically was not isolated in that study. A crossover trial (n=13) found dose-dependent increases in serum palmitoleic acid following seed oil supplementation, but no statistically significant changes in fasting glucose, total cholesterol, LDL, or triglycerides were observed. The overall clinical evidence base is preliminary, with studies limited by very small sample sizes, short durations, and heterogeneous preparations mixing seed and berry pulp oils. Larger, well-controlled trials are needed before definitive efficacy claims can be supported.

Nutritional Profile

Seabuckthorn seed oil is composed primarily of fatty acids (~90-95% of total composition) with a distinctive profile: oleic acid (omega-9, ~15-24%), linoleic acid (omega-6, ~32-40%), alpha-linolenic acid (omega-3, ~25-35%), and palmitic acid (~5-9%). Notably lower in palmitoleic acid (omega-7, ~1-3%) compared to seabuckthorn pulp/berry oil, which is a key distinguishing feature. Contains tocopherols (vitamin E complex) at approximately 100-200 mg/100g, primarily gamma- and alpha-tocopherol isoforms with antioxidant activity. Phytosterols present at ~400-600 mg/100g, predominantly beta-sitosterol, campesterol, and stigmasterol, which contribute to cholesterol-modulating potential. Carotenoids are present but at substantially lower concentrations than pulp oil (~10-40 mg/100g vs. ~300+ mg/100g in pulp oil). Contains trace phospholipids including phosphatidylcholine and phosphatidylethanolamine. Polyphenolic compounds including isorhamnetin and quercetin derivatives are present at low concentrations. No meaningful protein, carbohydrate, or dietary fiber content as an extracted seed oil. Bioavailability note: omega-3 and omega-6 fatty acids are in triglyceride form, offering moderate bioavailability; co-ingestion with food enhances absorption. The high polyunsaturated fatty acid content (~60-70% PUFAs) makes it susceptible to oxidation; bioavailability may be compromised in poorly stored or oxidized preparations.

Preparation & Dosage

Clinically studied doses: Seed oil capsules 380-1520 mg/day of palmitoleic acid content (divided doses, morning/evening); Berry oil 5 g/day for 4 weeks. No standardization details provided beyond palmitoleic acid content. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Fish oil, Vitamin E, Coenzyme Q10, Evening primrose oil, Astaxanthin

Safety & Interactions

Seabuckthorn seed oil is generally well tolerated at typical supplemental doses of 1–5 grams per day, with no serious adverse events reported in small clinical trials. Due to its antiplatelet properties mediated by altered thromboxane A2 production, caution is warranted when combining it with anticoagulant or antiplatelet drugs such as warfarin, clopidogrel, or aspirin, as additive bleeding risk is plausible. Individuals with known allergies to Elaeagnaceae family plants should avoid use, and pregnant or breastfeeding women should consult a physician before supplementing due to insufficient safety data in those populations. High-dose intake may theoretically cause gastrointestinal discomfort such as loose stools due to the high polyunsaturated fat content.